Gelion PLC (GB:GELN)
LSE:GELN
GELN Stock Chart & Stats
18.50 p
1.00 p(6.25%)
At close: 4:00 PM EST
18.50 p
1.00 p(6.25%)
Day’s Range― - ―
52-Week Range9.20 p - 30.00 p
Previous CloseN/A
Volume5.00K
Average Volume (3M)395.75K
Market Cap
£30.97M
Enterprise Value13.41M
Total Cash (Recent Filing)£10.52M
Total Debt (Recent Filing)£0.00
Price to Earnings (P/E)―
Beta-0.06
Next Earnings
Nov 11, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding229,421,460
10 Day Avg. Volume121,404
30 Day Avg. Volume395,753
Financial Highlights & Ratios
PEG Ratio0.17
Price to Book (P/B)3.53
Price to Sales (P/S)38.63
P/FCF Ratio-7.13
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Conservative Balance Sheet / Very Low LeverageExtremely low debt reduces near-term solvency pressure and preserves strategic optionality while Gelion continues R&D and scale-up. This structural financial flexibility lowers forced refinancing risk and supports multi‑quarter commercialization work funded by grants and targeted capex.
Tangible Technical Milestones & Strategic PartnersSuccessful pouch‑cell prototyping with TDK and Gen‑3 cells from QinetiQ materially de‑risks core chemistry integration. Durable partnerships and validated material transfers accelerate commercialization pathways, improve credibility with OEMs, and shorten technical validation cycles.
Non‑dilutive Grant Funding And Disciplined CapexIncreased government grants and targeted small capex demonstrate ability to fund scale-up without heavy dilution. Reliance on non‑dilutive funding and disciplined equipment spend improves runway and supports stepwise commercial scale, preserving shareholder equity while validating economics.
Bears Say
Persistent Negative Operating And Free Cash FlowConsistent cash burn signals ongoing funding dependence until commercial revenue scales. Weak cash generation constrains self‑funding of manufacturing scale, increases dilution or debt risk over time, and limits flexibility to absorb schedule slips or extended validation cycles.
Very Small, Volatile Revenue And Delayed Integration IncomeLow and volatile sales with deferred Integration revenue prolong the path to break‑even. Structural reliance on grant and partner funding until 2027+ raises execution risk, makes unit economics unproven at scale, and extends time before the business can self‑sustain cash needs.
Manufacturing Yield, Calendar‑life Validation And Partner Disruption RiskOutstanding yield/process engineering and incomplete calendar‑life validation are material technical gatekeepers for commercial economics. Combined with partner disruption (Ionblox), these structural execution risks could delay customer adoption and raise commercialization costs over multiple quarters.
Gelion PLC News
GELN FAQ
What was Gelion PLC’s price range in the past 12 months?
Gelion PLC lowest share price was 9.20 p and its highest was 30.00 p in the past 12 months.
What is Gelion PLC’s market cap?
Gelion PLC’s market cap is £30.97M.
When is Gelion PLC’s upcoming earnings report date?
Gelion PLC’s upcoming earnings report date is Nov 11, 2026 which is in 215 days.
How were Gelion PLC’s earnings last quarter?
Gelion PLC released its earnings results on Mar 02, 2026. The company reported -0.017 p earnings per share for the quarter, missing the consensus estimate of N/A by -0.017 p.
Is Gelion PLC overvalued?
According to Wall Street analysts Gelion PLC’s price is currently Overvalued.
Does Gelion PLC pay dividends?
Gelion PLC does not currently pay dividends.
What is Gelion PLC’s EPS estimate?
Gelion PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Gelion PLC have?
Gelion PLC has 229,421,460 shares outstanding.
What happened to Gelion PLC’s price movement after its last earnings report?
Gelion PLC reported an EPS of -0.017 p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 8.333%.
Which hedge fund is a major shareholder of Gelion PLC?
Currently, no hedge funds are holding shares in GB:GELN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Gelion PLC Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
1.31%
12-Months-Change
Fundamentals
Return on Equity
-42.23%
Trailing 12-Months
Asset Growth
59.13%
Trailing 12-Months
Company Description
Gelion PLC
Gelion plc engages in the research and development, design, manufacture, and sale of battery systems in the United Kingdom and internationally. The company offers zinc-bromide batteries under the Endure name. Its products are used in various applications, which include industrial light towers, solar and wind farms, desalination plants, mining pumps, passenger and heavy vehicles, electric buses and trains, and irrigation systems and other agricultural applications, as well as used by commercial and industrial enterprises and grid operators. The company was incorporated in 2015 and is headquartered in Eveleigh, Australia.
Technical Analysis
Options Prices
Currently, No data available
---